abstract |
The described invention relates to a pharmaceutical composition comprising at least one of a small molecule chemotherapeutic compound, an infinite proliferating human colon epithelial cell (HCEC) model, and a small molecule chemotherapeutic compound, which inhibits the measurable biological activity of selectively targeted and truncated APC proteins, A pharmaceutical composition comprising a carrier is provided. |